Methylprednisolone Acetate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00959 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | alopecia areata | KG + DL |
| 2 | alopecia mucinosa | KG + DL |
| 3 | telogen effluvium | KG + DL |
| 4 | Quinquaud’s folliculitis decalvans | KG + DL |
| 5 | alopecia antibody deficiency | KG + DL |
| 6 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 7 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 8 | atrichia with papular lesions | KG + DL |
| 9 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 10 | idiopathic steroid-sensitive nephrotic syndrome | KG + DL |
| 11 | sporadic idiopathic steroid-resistant nephrotic syndrome | KG + DL |
| 12 | PAGOD syndrome | KG + DL |
| 13 | disorder of GPI anchor biosynthesis | KG + DL |
| 14 | persistent polyclonal B-cell lymphocytosis | KG + DL |
| 15 | 46,XY disorder of sex development | KG + DL |
| 16 | hemoglobinuria | KG + DL |
| 17 | acquired aplastic anemia | KG + DL |
| 18 | necrobiosis lipoidica | KG + DL |
| 19 | articular cartilage disease | KG + DL |
| 20 | transient arthropathy | KG + DL |
| 21 | BENTA disease | KG + DL |
| 22 | severe combined immunodeficiency due to CARD11 deficiency | KG + DL |
| 23 | de Quervain disease | KG + DL |
| 24 | ganglion or cyst of synovium/tendon/bursa | KG + DL |
| 25 | shoulder impingement syndrome | KG + DL |
| 26 | Behcet syndrome arthropathy | KG + DL |
| 27 | ankylosis (disease) | KG + DL |
| 28 | prolapse of lacrimal gland | KG + DL |
| 29 | adrenomyodystrophy | KG + DL |
| 30 | spondyloepimetaphyseal dysplasia, Handigodu type | KG + DL |
| 31 | vertebral joint disease | KG + DL |
| 32 | alopecia universalis | KG + DL |
| 33 | platyspondylic dysplasia, Torrance type | KG + DL |
| 34 | Stickler syndrome | KG + DL |
| 35 | nephrotic syndrome of childhood - steroid sensitive | KG + DL |
| 36 | Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome | KG + DL |
| 37 | autoimmune myocarditis | KG + DL |
| 38 | megaepiphyseal dwarfism | KG + DL |
| 39 | Czech dysplasia, metatarsal type | KG + DL |
| 40 | IMAGe syndrome | KG + DL |
| 41 | spondylometaphyseal dysplasia, Schmidt type | KG + DL |
| 42 | subacute bursitis | KG + DL |
| 43 | Stickler syndrome, type I, nonsyndromic ocular | KG + DL |
| 44 | anti-glomerular basement membrane disease | KG + DL |
| 45 | mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis | KG + DL |
| 46 | spondyloperipheral dysplasia-short ulna syndrome | KG + DL |
| 47 | pemphigus vegetans | KG + DL |
| 48 | Sjogren syndrome | KG + DL |
| 49 | primary hypereosinophilic syndrome | KG + DL |
| 50 | avascular necrosis of femoral head, primary | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.